Application 090141
- Type
- ANDA
- Sponsor
- TEVA PHARMS USA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TADALAFIL | TADALAFIL | TABLET;ORAL | 2.5MG | No | No |
| 002 | TADALAFIL | TADALAFIL | TABLET;ORAL | 5MG | No | No |
| 003 | TADALAFIL | TADALAFIL | TABLET;ORAL | 10MG | No | No |
| 004 | TADALAFIL | TADALAFIL | TABLET;ORAL | 20MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A090141-001 | TADALAFIL | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2018-05-22 | |
| A090141-002 | TADALAFIL | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2018-05-22 | |
| A090141-003 | TADALAFIL | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2018-05-22 | |
| A090141-004 | TADALAFIL | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2018-05-22 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A090141-001 | AB1 |
| A090141-002 | AB1 |
| A090141-003 | AB1 |
| A090141-004 | AB1 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A090141-001 | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2018-05-22 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A090141-002 | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2018-05-22 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A090141-003 | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2018-05-22 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A090141-004 | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2018-05-22 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A090141-001 | AB1 | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A090141-002 | AB1 | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A090141-003 | AB1 | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A090141-004 | AB1 | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tadalafil | TADALAFIL | REMEDYREPACK INC. | 415bd983-86f3-4f38-917a-9805024f31cb | 2026-07-09 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Bryant Ranch Prepack | 07567ae5-7345-4ab1-9b2c-c586c4da0427 | 2026-06-24 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| TADALAFIL | TADALAFIL | REMEDYREPACK INC. | cec49f6c-71f1-4de7-b515-1612ae16e5db | 2026-06-11 | Warnings, Adverse reactions | TADALAFIL TADALAFIL |
| TADALAFIL | TADALAFIL | REMEDYREPACK INC. | 89a33a41-0f01-4f29-8b2f-769d649fbdcb | 2026-06-10 | Warnings, Adverse reactions | TADALAFIL TADALAFIL |
| Cialis | TADALAFIL | Eli Lilly and Company | bcd8f8ab-81a2-4891-83db-24a0b0e25895 | 2026-06-03 | Warnings, Adverse reactions | TADALAFIL |
| TADALAFIL | TADALAFIL | Bryant Ranch Prepack | b3a58c17-f260-4125-abd1-27da00bb0719 | 2026-05-29 | Warnings, Adverse reactions | TADALAFIL TADALAFIL |
| Tadalafil | TADALAFIL | REMEDYREPACK INC. | ad288e9d-020a-43a0-9c07-320c5c3bbc1e | 2026-05-27 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| tadalafil | TADALAFIL | Redpharm Drug | 52505a7a-e3dd-7c4e-e063-6294a90a1473 | 2026-05-21 | Warnings, Adverse reactions | tadalafil TADALAFIL |
| TADALAFIL | TADALAFIL | NuCare Pharmaceuticals,Inc.. | 16f13179-7c87-aa6c-e063-6294a90a93eb | 2026-05-19 | Warnings, Adverse reactions | TADALAFIL TADALAFIL |
| Tadalafil | TADALAFIL | Bryant Ranch Prepack | 2c2ec257-06bc-4ca4-9cf3-d0f49980e374 | 2026-05-14 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Bryant Ranch Prepack | aa8d165b-0c7d-497a-b56a-7c62ebc0a5d2 | 2026-05-13 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Bryant Ranch Prepack | f8def23c-55ea-4796-9735-dbcb25104835 | 2026-05-13 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Bryant Ranch Prepack | c835a34a-9bae-4d88-b951-1b78ab92f388 | 2026-05-13 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Umedica Laboratories USA Inc. | 6caf3b55-9bf4-4355-9e25-8bf368943fdd | 2026-04-26 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| TADALAFIL | TADALAFIL | REMEDYREPACK INC. | 82dfea4c-9fe5-438a-917f-8f7d395ee8ca | 2026-04-23 | Warnings, Adverse reactions | TADALAFIL TADALAFIL |
| Tadalafil | TADALAFIL | Accord Healthcare Inc. | eedf3ad9-7d40-496d-b1a9-6200010c18e1 | 2026-04-16 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Amneal Pharmaceuticals NY LLC | 90f38460-62ad-492e-a3da-403d5a5a5d86 | 2026-04-15 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| TADALAFIL | TADALAFIL | Aphena Pharma Solutions - Tennessee, LLC | 351e28ca-3ae6-e535-e063-6394a90a9fb7 | 2026-03-23 | Warnings, Adverse reactions | TADALAFIL TADALAFIL |
| TADALAFIL | TADALAFIL | Torrent Pharmaceuticals Limited | 88132351-7fee-47ef-8007-ef2777543299 | 2026-03-05 | Warnings, Adverse reactions | TADALAFIL TADALAFIL |
| TADALAFIL | TADALAFIL | HEC Pharm USA Inc. | a0f728b6-2cc6-cb65-e053-2a95a90ab142 | 2026-03-05 | Warnings, Adverse reactions | TADALAFIL TADALAFIL |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0093-3016 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3016 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3016 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3016 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3016 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3016 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3016 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3017 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3017 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3017 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3017 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3017 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3017 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3017 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3018 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3018 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3018 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3018 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3018 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3018 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3018 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3019 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3019 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3019 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3019 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3019 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3019 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3019 | Tadalafil | Tadalafil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 42291-786 | Tadalafil | Tadalafil | Avkare | ANDA | Current |
| 42291-786 | Tadalafil | Tadalafil | Avkare | ANDA | Current |
| 42291-787 | Tadalafil | Tadalafil | AvKARE, Inc. | ANDA | Current |
| 42291-787 | Tadalafil | Tadalafil | AvKARE | ANDA | Current |
| 42291-788 | Tadalafil | Tadalafil | AvKARE, Inc. | ANDA | Current |
| 42291-788 | Tadalafil | Tadalafil | AvKARE | ANDA | Current |
| 42291-789 | Tadalafil | Tadalafil | AvKARE, Inc. | ANDA | Current |
| 42291-789 | Tadalafil | Tadalafil | AvKARE | ANDA | Current |
| 71205-418 | Tadalafil | Tadalafil | Proficient Rx LP | ANDA | Current |
| 71610-353 | Tadalafil | Tadalafil | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |
| 71610-354 | Tadalafil | Tadalafil | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |
| 76519-1225 | TADALAFIL | TADALAFIL | H.J. Harkins Company, Inc. | ANDA | Current |
| 76519-1226 | TADALAFIL | TADALAFIL | H.J. Harkins Company, Inc. | ANDA | Current |
| 76519-1227 | TADALAFIL | TADALAFIL | H.J. Harkins Company, Inc. | ANDA | Current |